Research funded by taxpayers over the last 50 years has revolutionized cancer treatment, and now scientists are targeting mutations in patient DNA with tailored therapies.
Research funded by taxpayers over the last 50 years has revolutionized cancer treatment, and now scientists are targeting mutations in patient DNA with tailored therapies.